User profiles for Reem Elajez

Reem Elajez

Clinical pharmacist
Verified email at hamad.qa
Cited by 141

[HTML][HTML] Pharmacokinetics, pharmacodynamics, and dosing considerations of novel β-lactams and β-lactam/β-lactamase inhibitors in critically ill adult patients: focus …

D Bakdach, R Elajez, AR Bakdach, A Awaisu… - Journal of Clinical …, 2022 - mdpi.com
Objective: Dose optimization of novel β-lactam antibiotics (NBLA) has become necessary
given the increased prevalence of multidrug-resistant infections in intensive care units coupled …

[HTML][HTML] Hospital pharmacists' self-evaluation of their competence and confidence in conducting pharmacy practice research

A Awaisu, D Bakdach, RH Elajez, M Zaidan - Saudi Pharmaceutical Journal, 2015 - Elsevier
Objectives: Research is essential to the advancement of pharmacy practice and healthcare.
Pharmacists have a pivotal role to play in this strategy. However, there is a paucity of data …

[HTML][HTML] The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study

…, AM Akkari, A Baiou, B Alhariri, R Elajez… - BMC infectious …, 2020 - Springer
Background There are limited data on Coronavirus Disease 2019 (COVID-19) outcomes at
a national level, and none after 60 days of follow up. The aim of this study was to describe …

[HTML][HTML] Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar

D Abushanab, M Atchan, R Elajez, M Elshafei… - PLoS …, 2023 - journals.plos.org
Background With an increasingly strained health system budgets, healthcare services need
to continually demonstrate evidence of economic benefits. This study sought to evaluate the …

[HTML][HTML] Efficacy and safety of intravenous fosfomycin for the treatment of difficult-to-treat Gram-negative bacterial infections

TAK Abdallah, R Elajez, TB Ibrahim, AB Alimam… - Journal of Infection and …, 2021 - Elsevier
We reviewed the efficacy and safety of intravenous (IV) fosfomycin for the treatment of
infections caused by Gram-negative bacteria (GNB) with difficult-to-treat resistance (DTR). Data …

Safety evaluation of intravenous immunoglobulin in pediatric patients: a retrospective, 1-year observational study

R Elajez, A Ezzeldin, H Gaber - Therapeutic Advances in …, 2019 - journals.sagepub.com
Background: Intravenous immunoglobulin (IVIG) is a pooled human plasma protein that has
shown efficacy in treating a variety of disorders. IVIG is generally well tolerated and has a …

[HTML][HTML] Management of anaphylaxis in children: a survey of parents and school personnel in Qatar

…, M Charlson, H Jama, F Zakri, RH Elajez… - BMJ paediatrics …, 2017 - ncbi.nlm.nih.gov
Background Allergies are a growing health concern with a significant impact on quality of life
and healthcare costs. It is critical to develop an appropriate care plan to deal with children’s …

Thrombocytopenia associated with teicoplanin use: a retrospective observational study

R Elajez, I Abdallah, D Bakdach… - Annals of …, 2022 - journals.sagepub.com
Background: Contradictory studies reporting vast heterogeneity in the teicoplanin-induced
thrombocytopenia (TIT) incidence exist. Objective: To identify the incidence of TIT associated …

Trimethoprim–Sulfamethoxazole: new lessons on an old antimicrobial; a retrospective analysis

D Bakdach, R Elajez - Journal of Pharmaceutical Health …, 2020 - academic.oup.com
Objective This study aimed to evaluate the appropriateness of TMP-SMX prescriptions as part
of drug utilization review. Method Charts of all patients (adults and paediatrics) admitted to …

[PDF][PDF] Does Trimethoprim-Sulfamethoxazole prophylaxis induce myelosuppression in primary immune deficiency disease patients; A retrospective, 3 groups …

R Elajez, S Nisar, M Adeli - Asian Pacific Journal of Allergy and …, 2023 - apjai-journal.org
Background: The possible myelosuppression side effect of Trimethoprim-Sulfamethoxazole (TMP-SMX)
on primary immune deficiency (PID) patients has not been established yet. …